Recombinant swine skin development substance (rrhEGF) is receiving increased interest as a valuable strategy in the field of wound therapy. This bioactive agent, produced through molecular technology, offers a https://recombinant-porcine-egf343263.pages10.com/engineered-pig-cutaneous-development-factor-a-significant-tool-for-wound-regeneration-78470603